- Home
- App Analytics
- Biosimilar
- Biosimilar Vs. DRUGDOCS
Biosimilar vs DRUGDOCS Usage & Stats
Biologic drugs offer important treatment options for patients suffering from auto-immune disorders such as rheumatoid arthritis and for common cancers including breast and colon. Biosimilar and interchangeable products, which can loosely be thought of as ‘generic’ biologics, are important for promoting competition and driving down costs. The FDA maintains a list of approved biosimilars in the Purple Book. The Biosimilar iOS app provides a handy reference to the Purple Book as well as important information related to prescribing and dispensing for clinicians and pharmacists navigating this complex area of drug therapeutics.
** Disclaimer ** - non-medical users should ask for a doctor’s advice in addition to using this app and before making any medical decisions.
- Apple App Store
- Paid
- Medical
Store Rank
- -
DRUGDOCS® provides health professionals with current, evidence-based information on the drugs they prescribe with direct access to publications.
- Apple App Store
- Free
- Medical
Store Rank
- -
Biosimilar vs. DRUGDOCS ranking comparison
Compare Biosimilar ranking trend in the past 28 days vs. DRUGDOCS
Biosimilar#132
Rank
Biosimilar vs. DRUGDOCS ranking by country comparison
Compare Biosimilar ranking trend in the past 28 days vs. DRUGDOCS
All categories
No Data Available
Medical
Compare to any site with our free trial
Biosimilar VS.
DRUGDOCS
December 19, 2024